First Horizon Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
RG
PAI
First Horizon Advisors's FOLD Position: Q1 2025 in Review
First Horizon Advisors sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 2,238 shares — an estimated $20.7K sold.
First Horizon Advisors first reported a position in FOLD in Q1 2021 and held it in 15 quarters. The position peaked at $47.9K in Q4 2023. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.
- First Horizon Advisors reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
- First Horizon Advisors sold 2,238 Amicus Therapeutics shares in Q1 2025, an estimated $20.7K.
- First Horizon Advisors first reported a position in Amicus Therapeutics in Q1 2021 and held it in 15 quarters.
- First Horizon Advisors's Amicus Therapeutics position peaked at $47.9K in Q4 2023.
- 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.
Based on First Horizon Advisors's 13F filing for Q1 2025, filed 28 Apr 2025.